Inventor profile of:

Yanjun LIU

City:

Shanghai

Country:

China

Published Applications:

27

Last publication date:

2026-05-21

Top Assignees for applications by Yanjun LIU

The entities that hold a legal rights for patent applications filed by inventor LIU Yanjun:

Recent patent applications by LIU Yanjun

Yanjun LIU from Shanghai, CN has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-05-21
US20260137796A1
Human necessities

PHARMACEUTICAL COMBINATIONS FOR SUBCUTANEOUS ADMINISTRATION AND USE THEREOF

#2 | 2025-08-14
US20250257346A1
Chemistry; metallurgy

USE OF MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE

#3 | 2025-05-08
US20250145730A1
Chemistry; metallurgy

ANTI-IMMUNOGLOBULIN DEGRADING ENZYME-DIGESTED FC VARIANT

#4 | 2025-03-27
US20250099557A1
Human necessities

ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION

#5 | 2025-03-20
US20250090523A1
Human necessities

PHARMACEUTICAL COMPOSITION OR DRUG KIT FOR ALLEVIATING OR TREATING FIBROTIC DISEASES, AND USE THEREOF

#6 | 2025-02-13
US20250049849A1
Human necessities

PRODUCT AND METHOD FOR TREATING THROMBOCYTOPENIA

#7 | 2025-02-06
US20250043026A1
Chemistry; metallurgy

FC POLYPEPTIDE HAVING ALTERED GLYCOSYLATION MODIFICATION

#8 | 2024-10-10
US20240336908A1
Chemistry; metallurgy

Use of mutant of immunoglobulin degrading enzyme IdeE

#9 | 2024-10-03
US20240327510A1
Chemistry; metallurgy

DRUG FOR PREVENTING, ALLEVIATING OR TREATING MUCOSAL ADHESION AND USE THEREOF

#10 | 2024-09-19
US20240307346A1
Human necessities

METHOD FOR TREATING OR PREVENTING A DISEASE OF INCOMPLETE IMMUNE RECONSTITUTION IN AIDS USING (5R)-5-HYDROXYTRIPTOLIDE

#11 | 2023-11-23
US20230374083A1
Chemistry; metallurgy

PHARMACEUTICAL COMBINATION AND USE THEREOF

#12 | 2023-11-16
US20230364207A1
Human necessities

MUTANT OF IMMUNOGLOBULIN DEGRADING ENZYME IDEE

#13 | 2023-10-19
US20230334047A1
Physics

Query processing based on stochastic prediction model

#14 | 2023-09-07
US20230277633A1
Human necessities

PHARMACEUTICAL COMPOSITION OF ENZYMES AND VIRUSES AND APPLICATION THEREOF

#15 | 2023-04-27
US20230128597A1
Physics

Method, device, and computer program product for scheduling tour guiding resources

#16 | 2022-12-01
US20220380433A1
Chemistry; metallurgy

TMEM59 PROTEIN DIMER OR CHIMERIC EXPRESSION RECEPTOR IMPROVING T CELL FUNCTION

#17 | 2022-10-13
US20220324868A1
Chemistry; metallurgy

Pyrazolone-Fused Pyrimidine Compound, and Preparation Method and Use Therefor

#18 | 2022-08-18
US20220259210A1
Chemistry; metallurgy

Pyrazolone-Fused Pyrimidine Compound, Preparation Method for Same and Applications Thereof

#19 | 2022-07-21
US20220226334A1
Human necessities

ANTIBODY CONJUGATE AND APPLICATION OF PHARMACEUTICAL COMPOSITION THEREOF

#20 | 2022-06-23
US20220195397A1
Chemistry; metallurgy

IMMUNE CELL CONTAINING TUMOR ANTIGEN RECOGNITION RECEPTOR AND APPLICATION THEREOF

#21 | 2021-02-25
US20210052541A1
Human necessities

Application of (5R)-5-Hydroxytriptolide in Preparation of Drugs

#22 | 2020-07-30
US20200239470A1
Chemistry; metallurgy

Substituted pyrimidines as cyclin-dependent kinase inhibitors

#23 | 2020-06-18
US20200190091A1
Chemistry; metallurgy

Nitrogenous heterocyclic compound, preparation method, intermediate, composition, and application

#24 | 2019-10-03
US20190300491A1
Chemistry; metallurgy

Salt of quinazoline derivative, preparation method therefor and application thereof

#25 | 2019-03-28
US20190091226A1
Human necessities

Nitrogenous heterocyclic compound, preparation method, intermediate, composition and use

#26 | 2019-01-10
US20190010153A1
Chemistry; metallurgy

Substituted pyrimidines as cyclin-dependent kinase inhibitors

#27 | 2011-05-19
US20110117082A1
Chemistry; metallurgy

Soluble tumor necrosis factor receptor mutant

InventorID:

2397253 ⎘